Trial
NCT00427427
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
—
Condition
Breast Cancer
Intervention
Trastuzumab
Why stopped
lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-01